Orexigen’s Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight
This article is for subscribers only.
Obese patients who took Orexigen Therapeutics Inc.’s experimental pill combining an anti-addiction drug and an antidepressant lost more weight than those who took a placebo, a company-sponsored study found.
Patients who took the Orexigen pill, Contrave, and were given diet and exercise suggestions shed 5 percent to 6 percent of their body weight compared with an average weight loss of 1.3 percent among those taking placebos.